Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene protein c‑akt (AKT), also known as Protein Kinase B (PKB), is a serine/threonine kinase that plays a central role in multiple cellular processes, including cell survival, growth, proliferation, metabolism, and angiogenesis. Dysregulation or hyperactivation of AKT is implicated in various diseases, including cancer and type 2 diabetes.
Akt inhibitors block the kinase activity of AKT, preventing phosphorylation of downstream targets and inhibiting AKT-mediated cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein c‑akt (AKT).